Physician profile
David Mendelson
NPI 1982631065
$822.89
in general payments reported to CMS, 2019-2025
22 companies · $46.88 in 2025
The $46.88 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2022: $18.39 · 2025: $46.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $46.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $46.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $78.52 | 2019 | |
| Pfizer INC. | $76.48 | 2019 | |
| Janssen Biotech, INC. | $73.89 | 2019 | |
| Merck Sharp & Dohme LLC | $68.81 | 2019 | |
| Aidoc Medical LTD | $46.88 | 2025 | Briefcase |
| E.R. Squibb & Sons, L.L.C. | $46.11 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.95 | 2019 | |
| Genentech USA, INC. | $41.27 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $38.75 | 2019 | |
| Puma Biotechnology, INC. | $35.54 | 2019 | |
| Allergan, INC. | $34.98 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.94 | 2019 | |
| Genzyme Corporation | $28.37 | 2019 | |
| Kyowa Kirin, INC. | $23.52 | 2019 | |
| Amgen INC. | $23.51 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $23.44 | 2019 | |
| Daiichi Sankyo INC. | $19.74 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $18.42 | 2019 | |
| Stryker Corporation | $18.39 | 2022 | |
| Astellas Pharma US INC | $18.03 | 2019 | |
| Abbvie INC. | $17.62 | 2019 | |
| Exelixis INC. | $16.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mendelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.